Zogenix, Inc.
22
1
2
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
9.1%
2 terminated/withdrawn out of 22 trials
88.9%
+2.4% vs industry average
32%
7 trials in Phase 3/4
31%
5 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
Fenfluramine for Adult Dravet Patients
Role: collaborator
A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.
Role: lead
A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome
Role: lead
Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes
Role: collaborator
European Non-interventional Study on Refractory Epilepsy With Developmental Delay
Role: lead
ZX008 Expanded Access Protocol
Role: lead
Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy
Role: collaborator
A Study on the Effects of Repeat Doses of Intraject® Sumatriptan on Local Site Signs
Role: lead
Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain
Role: lead
Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) in Subjects With Renal Impairment
Role: lead
A Multicenter Active Comparator Study of HC-ER in Adults Following Bunionectomy Surgery
Role: lead
A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System
Role: lead
Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Controlled-Release (HC-CR) in Subjects With Hepatic Impairment
Role: lead
A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack
Role: lead
To Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release Capsules
Role: lead
A Study to Determine the Influence of Co-ingestion of Alcohol on Hydrocodone Bitartrate Extended Release (HC-ER)
Role: lead
A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia
Role: lead
A Study on the Intraject Instructions for Use
Role: lead
A Safety, Tolerability and Pharmacokinetic Dose Escalation Study of HC-ER in Patients With Osteoarthritis Pain
Role: lead
Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain
Role: lead